Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A common haplotype within the PON1 promoter region is associated with sporadic ALS.

Landers JE, Shi L, Cho TJ, Glass JD, Shaw CE, Leigh PN, Diekstra F, Polak M, Rodriguez-Leyva I, Niemann S, Traynor BJ, McKenna-Yasek D, Sapp PC, Al-Chalabi A, Wills AM, Brown RH Jr.

Amyotroph Lateral Scler. 2008 Oct;9(5):306-14. doi: 10.1080/17482960802233177.

2.

Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.

Wills AM, Landers JE, Zhang H, Richter RJ, Caraganis AJ, Cudkowicz ME, Furlong CE, Brown RH Jr.

Neurology. 2008 Mar 18;70(12):929-34. doi: 10.1212/01.wnl.0000305956.37931.dd.

PMID:
18347314
3.

Paraoxonase cluster polymorphisms are associated with sporadic ALS.

Saeed M, Siddique N, Hung WY, Usacheva E, Liu E, Sufit RL, Heller SL, Haines JL, Pericak-Vance M, Siddique T.

Neurology. 2006 Sep 12;67(5):771-6. Epub 2006 Jul 5.

PMID:
16822964
4.

Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis.

Cronin S, Greenway MJ, Prehn JH, Hardiman O.

J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):984-6.

5.

Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden.

Valdmanis PN, Kabashi E, Dyck A, Hince P, Lee J, Dion P, D'Amour M, Souchon F, Bouchard JP, Salachas F, Meininger V, Andersen PM, Camu W, Dupré N, Rouleau GA.

Neurology. 2008 Aug 12;71(7):514-20. doi: 10.1212/01.wnl.0000324997.21272.0c.

PMID:
18695162
6.

A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.

Morahan JM, Yu B, Trent RJ, Pamphlett R.

Neurotoxicology. 2007 May;28(3):532-40. Epub 2006 Nov 26.

PMID:
17204329
7.

A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.

Wills AM, Cronin S, Slowik A, Kasperaviciute D, Van Es MA, Morahan JM, Valdmanis PN, Meininger V, Melki J, Shaw CE, Rouleau GA, Fisher EM, Shaw PJ, Morrison KE, Pamphlett R, Van den Berg LH, Figlewicz DA, Andersen PM, Al-Chalabi A, Hardiman O, Purcell S, Landers JE, Brown RH Jr.

Neurology. 2009 Jul 7;73(1):16-24. doi: 10.1212/WNL.0b013e3181a18674. Epub 2009 Mar 25.

8.

Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis.

Lee YH, Kim JH, Seo YH, Choi SJ, Ji JD, Song GG.

Neurol Sci. 2015 Jan;36(1):11-20. doi: 10.1007/s10072-014-1979-y. Epub 2014 Oct 10. Review.

PMID:
25301263
9.

Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.

Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, Sapp PC, van Vught PW, McKenna-Yasek DM, Blauw HM, Cho TJ, Polak M, Shi L, Wills AM, Broom WJ, Ticozzi N, Silani V, Ozoguz A, Rodriguez-Leyva I, Veldink JH, Ivinson AJ, Saris CG, Hosler BA, Barnes-Nessa A, Couture N, Wokke JH, Kwiatkowski TJ Jr, Ophoff RA, Cronin S, Hardiman O, Diekstra FP, Leigh PN, Shaw CE, Simpson CL, Hansen VK, Powell JF, Corcia P, Salachas F, Heath S, Galan P, Georges F, Horvitz HR, Lathrop M, Purcell S, Al-Chalabi A, Brown RH Jr.

Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9004-9. doi: 10.1073/pnas.0812937106. Epub 2009 May 18.

10.

Association analysis of PON polymorphisms in sporadic ALS in a Chinese population.

Chen Y, Huang R, Chen K, Song W, Yang Y, Zhao B, Li J, Shang HF.

Neurobiol Aging. 2012 Dec;33(12):2949.e1-3. doi: 10.1016/j.neurobiolaging.2012.06.024. Epub 2012 Aug 9.

PMID:
22884547
11.

Lack of association of PON polymorphisms with sporadic ALS in an Italian population.

Ricci C, Battistini S, Cozzi L, Benigni M, Origone P, Verriello L, Lunetta C, Cereda C, Milani P, Greco G, Patrosso MC, Causarano R, Caponnetto C, Giannini F, Corbo M, Penco S.

Neurobiol Aging. 2011 Mar;32(3):552.e7-13. doi: 10.1016/j.neurobiolaging.2010.02.010. Epub 2010 Apr 9.

PMID:
20381198
12.

Large-scale pathways-based association study in amyotrophic lateral sclerosis.

Kasperaviciute D, Weale ME, Shianna KV, Banks GT, Simpson CL, Hansen VK, Turner MR, Shaw CE, Al-Chalabi A, Pall HS, Goodall EF, Morrison KE, Orrell RW, Beck M, Jablonka S, Sendtner M, Brockington A, Ince PG, Hartley J, Nixon H, Shaw PJ, Schiavo G, Wood NW, Goldstein DB, Fisher EM.

Brain. 2007 Sep;130(Pt 9):2292-301. Epub 2007 Apr 17.

PMID:
17439985
13.

Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients.

van Blitterswijk M, Blokhuis A, van Es MA, van Vught PW, Rowicka PA, Schelhaas HJ, van der Kooi AJ, de Visser M, Veldink JH, van den Berg LH.

Neurobiol Aging. 2012 Aug;33(8):1845.e1-3. doi: 10.1016/j.neurobiolaging.2012.01.007. Epub 2012 Feb 11.

PMID:
22330174
14.

Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.

Diekstra FP, Saris CG, van Rheenen W, Franke L, Jansen RC, van Es MA, van Vught PW, Blauw HM, Groen EJ, Horvath S, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, Robberecht W, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH Jr, Shatunov A, Shaw CE, Leigh PN, Al-Chalabi A, Ophoff RA, van den Berg LH, Veldink JH.

PLoS One. 2012;7(4):e35333. doi: 10.1371/journal.pone.0035333. Epub 2012 Apr 11.

15.

Paraoxonase gene polymorphisms and sporadic ALS.

Slowik A, Tomik B, Wolkow PP, Partyka D, Turaj W, Malecki MT, Pera J, Dziedzic T, Szczudlik A, Figlewicz DA.

Neurology. 2006 Sep 12;67(5):766-70. Epub 2006 Jul 5.

PMID:
16822965
16.

Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.

Bergström P, von Otter M, Nilsson S, Nilsson AC, Nilsson M, Andersen PM, Hammarsten O, Zetterberg H.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):130-7. doi: 10.3109/21678421.2013.839708. Epub 2013 Oct 8.

PMID:
24102512
17.

Interaction between PON1 and population density in amyotrophic lateral sclerosis.

Diekstra FP, Beleza-Meireles A, Leigh NP, Shaw CE, Al-Chalabi A.

Neuroreport. 2009 Jan 28;20(2):186-90. doi: 10.1097/WNR.0b013e32831af220.

PMID:
19104460
18.

Whole-genome analysis of sporadic amyotrophic lateral sclerosis.

Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, Halperin RF, Stamper C, Jensen KR, Letizia D, Hesterlee SE, Pestronk A, Levine T, Bertorini T, Graves MC, Mozaffar T, Jackson CE, Bosch P, McVey A, Dick A, Barohn R, Lomen-Hoerth C, Rosenfeld J, O'connor DT, Zhang K, Crook R, Ryberg H, Hutton M, Katz J, Simpson EP, Mitsumoto H, Bowser R, Miller RG, Appel SH, Stephan DA.

N Engl J Med. 2007 Aug 23;357(8):775-88. Epub 2007 Aug 1.

19.

Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.

Gupta N, Binukumar BK, Singh S, Sunkaria A, Kandimalla R, Bhansali A, Gill KD.

Gene. 2011 Nov 1;487(1):88-95. doi: 10.1016/j.gene.2011.07.011. Epub 2011 Jul 26.

PMID:
21803130
20.

Polymorphisms in the PON gene cluster are associated with Alzheimer disease.

Erlich PM, Lunetta KL, Cupples LA, Huyck M, Green RC, Baldwin CT, Farrer LA; MIRAGE Study Group.

Hum Mol Genet. 2006 Jan 1;15(1):77-85. Epub 2005 Nov 30.

PMID:
16319130

Supplemental Content

Support Center